Oncoceutics' Corporate Minority Round

Oncoceutics raised a round of funding on January 10, 2018. Investors include Frontida Biopharm.

Oncoceutics is a clinical-stage drug discovery and development company targeting the most potent suppressor pathways in human cancer. The first lead compound to result from this program is ONC201, a s…

Articles about Oncoceutics' Corporate Minority Round: